↑ Griebel G, Misslin R, Pawlowski M, Guardiola Lemaître B, Guillaumet G, Bizot-Espiard J. (1992). “Anxiolytic-like effects of a selective 5-HT1A agonist, S20244, and its enantiomers in mice”. Neuroreport. 3 (1): 84—86. DOI:10.1097/00001756-199201000-00022. PMID1351756.
↑ Simon P, Guardiola B, Bizot-Espiard J, Schiavi P, Costentin J. (1992). “5-HT1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonists”. Psychopharmacology (Berl). 108 (1–2): 47—50. DOI:10.1007/BF02245284. PMID1357709.
↑ Astier B, Lambás Señas L, Soulière F, Schmitt P, Urbain N, Rentero N, Bert L, Denoroy L, Renaud B, Lesourd M, Muñoz C, Chouvet G. (2003). “In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity”. Eur J Pharmacol. 459 (1): 17—26. DOI:10.1016/S0014-2999(02)02814-5. PMID12505530.
↑ Bardin L, Tarayre JP, Malfetes N, Koek W, Colpaert FC (April 2003). “Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain”. Pharmacology. 67 (4): 182—94. DOI:10.1159/000068404. PMID12595749.
↑ Bruins Slot LA, Koek W, Tarayre JP, Colpaert FC (April 2003). “Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640”. European Journal of Pharmacology. 466 (3): 271—9. DOI:10.1016/S0014-2999(03)01566-8. PMID12694810.
↑ Bardin L, Assié MB, Pélissou M, Royer-Urios I, Newman-Tancredi A, Ribet JP, Sautel F, Koek W, Colpaert FC (March 2005). “Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters”. The Journal of Pharmacology and Experimental Therapeutics. 312 (3): 1034—42. DOI:10.1124/jpet.104.077669. PMID15528450.
↑ Colpaert FC, Deseure K, Stinus L, Adriaensen H (February 2006). “High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning”. The Journal of Pharmacology and Experimental Therapeutics. 316 (2): 892—9. DOI:10.1124/jpet.105.095109. PMID16254131.
↑ Deseure K, Bréand S, Colpaert FC (July 2007). “Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist”. European Journal of Pharmacology. 568 (1—3): 134—41. DOI:10.1016/j.ejphar.2007.04.022. PMID17512927.
↑ Haj-Dahmane S, Jolas T, Laporte AM; et al. (April 1994). “Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat”. European Journal of Pharmacology. 255 (1–3): 185—96. DOI:10.1016/0014-2999(94)90097-3. PMID8026543.
↑ Monte AP, Marona-Lewicka D, Lewis MM, Mailman RB, Wainscott DB, Nelson DL, Nichols DE (June 1998). “Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity”. Journal of Medicinal Chemistry. 41 (12): 2134—45. DOI:10.1021/jm980076u. PMID9622555.
↑ Foreman MM, Fuller RW, Rasmussen K, Nelson DL, Calligaro DO, Zhang L, Barrett JE, Booher RN, Paget CJ, Flaugh ME (September 1994). “Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity”. The Journal of Pharmacology and Experimental Therapeutics. 270 (3): 1270—81. PMID7523657.
↑ Matsuda T., Yoshikawa T., Suzuki M., Asano S., Somboonthum P., Takuma K., Nakano Y., Morita T., Nakasu Y., Kim H. S.Novel benzodioxan derivative, 5-(3-[((2S)-1,4-benzodioxan-2- ylmethyl)aminopropoxy)-1,3-benzodioxole HCl (MKC-242), with a highly potent and selective agonist activity at rat central serotonin1A receptors.](англ.)// Japanese journal of pharmacology.— 1995.— Vol.69, no. 4.— P.357—366.— PMID 8786639.[исправить]
↑ Romero AG, Leiby JA, McCall RB, Piercey MF, Smith MW, Han F. (1993). “Novel 2-substituted tetrahydro-3H-benz[e]indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressants”. J Med Chem. 36 (15): 2066—2074. DOI:10.1021/jm00067a003. PMID8101876.
↑ McCall RB, Romero AG, Bienkowski MJ, Harris DW, McGuire JC, Piercey MF, Shuck ME, Smith MW, Svensson KA, Schreur PJ; et al. (1994). “Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist”. J Pharmacol Exp Ther. 271 (2): 875—883. PMID7965808.
↑ Winter JC, Timineri D (March 1999). “The discriminative stimulus properties of EGb 761, an extract of Ginkgo biloba”. Pharmacol. Biochem. Behav. 62 (3): 543–7. DOI:10.1016/S0091-3057(98)00190-7. PMID10080249.
Данная страница на сайте WikiSort.ru содержит текст со страницы сайта "Википедия".
Другой контент может иметь иную лицензию. Перед использованием материалов сайта WikiSort.ru внимательно изучите правила лицензирования конкретных элементов наполнения сайта.
2019-2025 WikiSort.ru - проект по пересортировке и дополнению контента Википедии